Target intelligence / Profile preview

Queuine tRNA-ribosyltransferase catalytic subunit 1 (QTRT1)

Target
QTRT1
Molecular classification
Enzyme (specifically, tRNA-guanine transglycosylase catalytic subunit), tRNA modification enzyme
01

Overview

Queuine tRNA-ribosyltransferase catalytic subunit 1 (QTRT1) is the catalytic core of the eukaryotic tRNA-guanine transglycosylase (TGT) enzyme complex responsible for post-transcriptional modification of select tRNAs. It catalyzes the exchange of guanine for queuine at the wobble position (position 34) of tRNAs for asparagine, aspartic acid, histidine, and tyrosine. This structural modification of tRNA is essential for proper decoding during translation and influences protein synthesis fidelity, cell signaling, and cellular growth pathways. QTRT1 requires heterodimerization with QTRTD1 for full activity. The protein is expressed in the cytoplasm and mitochondria, and its levels and activity are altered in certain cancers, impacting cell proliferation, migration, and junctional integrity. Aberrant queuine modification resulting from QTRT1 deficiency or dysregulation has been linked to tumorigenesis, neurodegeneration, microbiome-mediated physiology, and inflammation. Eukaryotes cannot synthesize queuine and must acquire it from diet and microbiota. Structural studies reveal a central (β/α)8 barrel and zinc-binding domain critical for its catalytic activity. No clinically approved drugs directly target QTRT1, but its functional and disease relevance make it a subject of ongoing research for biomarker and therapeutic development.

Other names
Queuine tRNA-ribosyltransferase catalytic subunit 1QTRT1TGTTGUTGuanine insertion enzymetRNA-guanine transglycosylaseFP323543-KD subunitQueuine tRNA-ribosyltransferase 1Catalytic subunitQueuine insertion enzymetRNA-guanine transglycosylase catalytic subunit 1
02

Mechanism of action

Hypothetical mechanisms include inhibition of enzymatic activity to perturb tRNA queuosine modification, thereby influencing translational fidelity and cell proliferation. No clinically validated drugs or inhibitors have been described

03

Biological functions

tRNA post-transcriptional modification (exchange of guanine for queuine at position 34 of select tRNAs)Regulation of protein translation/fidelityControl of cell proliferation and migrationRegulation of cell adhesion and tight junctionsModulation of cell signalingInfluence on gut-brain axis/neurotransmitter synthesis
04

Disease associations

Cancer (e.g., breast cancer, lung adenocarcinoma, colon adenocarcinoma)Neurodegenerative disease (e.g., relevance for neuronal function)InflammationMicrobiome-associated disorders
05

Safety considerations

Safety concerns are theoretical and relate to possible disruption of fundamental cell processes such as protein synthesis and cellular adhesion; given its importance in normal cell function, systemic inhibition may risk off-target toxicity, especially in rapidly dividing tissuesModulation of QTRT1 activity may potentially affect the gut-brain axis and microbiome-related homeostasis, with unclear but possibly broad physiological consequences
06

Interacting drugs

There are currently no approved or clinically established drugs directly interacting with QTRT1; research into modulators or inhibitors is at a very early stage or preclinical, and is not documented in available databases or published literature
07

Biomarkers

QTRT1 expression level and methylation status have been identified as potential biomarkers of prognosis, especially in cancers such as lung adenocarcinoma and breast cancer

Beyond the preview

Go deeper on Queuine tRNA-ribosyltransferase catalytic subunit 1 (QTRT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Queuine tRNA-ribosyltransferase catalytic subunit 1 (QTRT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call